DSpace Repository

Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)